CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series.

doi:10.1097/MD.0000000000011998

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series.

Medicine - 1 Sept 2018

Seripa Davide, Lozupone Madia, Miscio Giuseppe, Stella Eleonora, La Montagna Maddalena, Gravina Carolina, Urbano Maria, di Mauro Lazzaro, Daniele Antonio, Greco Antonio, Logroscino Giancarlo, Panza Francesco, Bellomo Antonello

Abstract excerpt

RATIONALE: In psychiatric disorders, interindividual differences in cytochrome P450 (CYP)2D6 (CYP2D6) enzymatic activity could be responsible of adverse drug reactions (ADRs) and therapeutic failures (TFs) for CYP2D6-metabolized drugs, contributing to the periodical hospital readmissions of the revolving door (RD) condition. PATIENT CONCERNS: We investigated CYP2D6 genotypes in a controlled series of 5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Bipolar Disorder

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Cytochrome P-450 CYP2D6

Share to Genotype

Share to Psychiatric Status Rating Scales

Share to Treatment Failure

Share to Weight Gain

Source

Open in PubMed Open full text

Identifiers

PMID: 30212929
DOI: 10.1097/MD.0000000000011998
PMCID: PMC6155952

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.